Goldenwell Biotech, Inc. filed its 10-K on Apr 13, 2023 for the period ending Dec 31, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | +241.30% | +241.30% | +241.30% |
1st Jan change | Capi. | |
---|---|---|
+241.30% | 19.8M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- GWLL Stock
- News Goldenwell Biotech, Inc.
- Goldenwell Biotech, Inc. Auditor Raises 'Going Concern' Doubt